146 related articles for article (PubMed ID: 36970725)
21. African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance.
Kryvenko ON; Balise R; Soodana Prakash N; Epstein JI
J Urol; 2016 Feb; 195(2):301-6. PubMed ID: 26341575
[TBL] [Abstract][Full Text] [Related]
22. Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer.
Sakiyama MJ; Espinoza I; Reddy A; de Carlo F; Kumar A; Levenson AS; Bae S; Zhou X; Claudio PP; Lewin J; Manucha V; Pound CR; Vijayakumar S; Gomez CR
Exp Mol Pathol; 2019 Jun; 108():173-182. PubMed ID: 31004600
[TBL] [Abstract][Full Text] [Related]
23. Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient.
Theodore S; Sharp S; Zhou J; Turner T; Li H; Miki J; Ji Y; Patel V; Yates C; Rhim JS
Int J Oncol; 2010 Dec; 37(6):1477-82. PubMed ID: 21042716
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.
Devaney JM; Wang S; Furbert-Harris P; Apprey V; Ittmann M; Wang BD; Olender J; Lee NH; Kwabi-Addo B
Epigenetics; 2015; 10(4):319-28. PubMed ID: 25864488
[TBL] [Abstract][Full Text] [Related]
25. Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.
Dovey ZS; Nair SS; Chakravarty D; Tewari AK
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1340. PubMed ID: 33599076
[TBL] [Abstract][Full Text] [Related]
26. Prostatic compensation of the vitamin D axis in African American men.
Richards Z; Batai K; Farhat R; Shah E; Makowski A; Gann PH; Kittles R; Nonn L
JCI Insight; 2017 Jan; 2(2):e91054. PubMed ID: 28138564
[No Abstract] [Full Text] [Related]
27. Interactions of
Lin HY; Callan CY; Fang Z; Tung HY; Park JY
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1067-1075. PubMed ID: 30914434
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial dysfunction and prostate cancer racial disparities among American men.
Chaudhary AK; O'Malley J; Kumar S; Inigo JR; Kumar R; Yadav N; Chandra D
Front Biosci (Schol Ed); 2017 Jan; 9(1):154-164. PubMed ID: 27814581
[TBL] [Abstract][Full Text] [Related]
29.
Ganaie AA; Beigh FH; Astone M; Ferrari MG; Maqbool R; Umbreen S; Parray AS; Siddique HR; Hussain T; Murugan P; Morrissey C; Koochekpour S; Deng Y; Konety BR; Hoeppner LH; Saleem M
Clin Cancer Res; 2018 Dec; 24(24):6421-6432. PubMed ID: 30087142
[TBL] [Abstract][Full Text] [Related]
30. A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance.
Olender J; Wang BD; Ching T; Garmire LX; Garofano K; Ji Y; Knox T; Latham P; Nguyen K; Rhim J; Lee NH
Mol Cancer Res; 2019 Oct; 17(10):2115-2125. PubMed ID: 31266816
[TBL] [Abstract][Full Text] [Related]
31. Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer.
Cullen J; Lynch JA; Klein EA; Van Den Eeden SK; Carroll PR; Mohler JL; Knezevic D; Farrington TA; Lu R
J Urol; 2021 Apr; 205(4):1047-1054. PubMed ID: 33493001
[TBL] [Abstract][Full Text] [Related]
32. High circulating estrogens and selective expression of ERβ in prostate tumors of Americans: implications for racial disparity of prostate cancer.
Abd Elmageed ZY; Moroz K; Srivastav SK; Fang Z; Crawford BE; Moparty K; Thomas R; Abdel-Mageed AB
Carcinogenesis; 2013 Sep; 34(9):2017-23. PubMed ID: 23658372
[TBL] [Abstract][Full Text] [Related]
33. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
Cullen J; Rosner IL; Brand TC; Zhang N; Tsiatis AC; Moncur J; Ali A; Chen Y; Knezevic D; Maddala T; Lawrence HJ; Febbo PG; Srivastava S; Sesterhenn IA; McLeod DG
Eur Urol; 2015 Jul; 68(1):123-31. PubMed ID: 25465337
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of a highly tumorigenic African American prostate cancer cell line, E006AA-hT.
Koochekpour S; Willard SS; Shourideh M; Ali S; Liu C; Azabdaftari G; Saleem M; Attwood K
Int J Biol Sci; 2014; 10(8):834-45. PubMed ID: 25076860
[TBL] [Abstract][Full Text] [Related]
35. Racial differences in prostate cancer growth: apoptosis and cell proliferation in Caucasian and African-American patients.
Guo Y; Sigman DB; Borkowski A; Kyprianou N
Prostate; 2000 Feb; 42(2):130-6. PubMed ID: 10617870
[TBL] [Abstract][Full Text] [Related]
36. Cell differentiation lineage in the prostate.
Wang Y; Hayward S; Cao M; Thayer K; Cunha G
Differentiation; 2001 Oct; 68(4-5):270-9. PubMed ID: 11776479
[TBL] [Abstract][Full Text] [Related]
37. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Yuan J; Kensler KH; Hu Z; Zhang Y; Zhang T; Jiang J; Xu M; Pan Y; Long M; Montone KT; Tanyi JL; Fan Y; Zhang R; Hu X; Rebbeck TR; Zhang L
PLoS Genet; 2020 Feb; 16(2):e1008641. PubMed ID: 32059012
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy.
Tosoian JJ; Almutairi F; Morais CL; Glavaris S; Hicks J; Sundi D; Humphreys E; Han M; De Marzo AM; Ross AE; Tomlins SA; Schaeffer EM; Trock BJ; Lotan TL
Eur Urol; 2017 May; 71(5):697-700. PubMed ID: 27477529
[TBL] [Abstract][Full Text] [Related]
39. A Recurrent ADPRHL1 Germline Mutation Activates PARP1 and Confers Prostate Cancer Risk in African American Families.
Zhang G; Wang Z; Bavarva J; Kuhns KJ; Guo J; Ledet EM; Qian C; Lin Y; Fang Z; Zabaleta J; Valle LD; Hu JJ; Mandal D; Liu W
Mol Cancer Res; 2022 Dec; 20(12):1776-1784. PubMed ID: 35816343
[TBL] [Abstract][Full Text] [Related]
40. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]